Private biopharmaceutical company focused on the development of therapies for retinal dystrophies.
- Year invested 2015
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website nightstartx.com/
- Company Status IPO/Acquired (by Biogen Inc.) (NASDAQ: NITE)